Merck says Covid pill ‘active’ against Omicron
Blocking sphingolipids counteracts muscular dystrophy
28 January 2022Lung abnormalities found in long COVID patients
29 January 2022Merck says Covid pill ‘active’ against Omicron
Merck’s anti-COVID pill remains “active” against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
